Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127169811 | 12716981 | 1 | I | 20160823 | 20160906 | 20160906 | EXP | TW-SEBELA IRELAND LIMITED-2016SEB01455 | SEBELA | NG CY, YEH Y-T, WANG C-W, ET AL.. IMPACT OF THE HLA-B*58:01 ALLELE AND RENAL IMPAIRMENT ON ALLOPURINOL-INDUCED CUTANEOUS ADVERSE REACTIONS. J INVEST DERMATOL (DOI: 10.1016/J.JID.2016.02.808). 2016;136:1373-1381 | 0.00 | Y | 0.00000 | 20160906 | OT | TW | TW |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127169811 | 12716981 | 1 | PS | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | U | 16084 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127169811 | 12716981 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127169811 | 12716981 | Drug reaction with eosinophilia and systemic symptoms | |
127169811 | 12716981 | Stevens-Johnson syndrome | |
127169811 | 12716981 | Toxic epidermal necrolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |